Avenue Therapeutics Inc. (ATXI) stock plunged during pre-market trading. What’s behind this?
Avenue Therapeutics Inc. (NASDAQ: ATXI) stock declined by 28.27% at last close while the ATXI stock price falls during pre-market as well, by 8.94%. Avenue Therapeutics is a pharmaceutical firm whose objective is to produce IV tramadol for patients diagnosed with severe pain in the United States as a viable alternative to conventional opioids. Avenue […]
Which Stocks Are Moving Today?
Avenue Therapeutics Inc. (NASDAQ:ATXI) shares traded over 29.00% higher in trading on Thursday after providing regulatory update for IV Tramadol. The consensus recommendation for the company is moderate buy. Shares of Phunware Inc. (PHUN) are 26.44% higher in trading this morning. Ascendiant Capital Markets issued a Buy recommendation for Phunware Inc. with a target price […]
